Research Dissemination
Publications
Roudi R, Pisani L, Pisani F, Kiru L, Daldrup-Link HE. Novel Clinically Translatable Iron Oxide Nanoparticle for Monitoring Anti-CD47 Cancer Immunotherapy. Invest Radiol. 2024 May 1;59(5):391-403. doi: 10.1097/RLI.0000000000001030. Epub 2023 Oct 9. PMID: 37812494; PMCID: PMC10997482.
Gammon ST, Cohen AS, Lehnert AL, Sullivan DC, Malyarenko D, Manning HC, Hormuth DA, Daldrup-Link HE, An H, Quirk JD, Shoghi K, Pagel MD, Kinahan PE, Miyaoka RS, Houghton AM, Lewis MT, Larson P, Sriram R, Blocker SJ, Pickup S, Badea A, Badea CT, Yankeelov TE, Chenevert TL. An Online Repository for Pre-Clinical Imaging Protocols (PIPs). Tomography. 2023 Mar 27;9(2):750-758. doi: 10.3390/tomography9020060. PMID: 37104131; PMCID: PMC10145184.
Ramasamy SK, Adams L, Marakote W, Roudi R, Pisani L, Moseley M, Daldrup-Link H. Protocol for measurement of tumor T2* relaxation times after iron oxide nanoparticle administration. Journal of Visualized Experiments 19;(195); 2023. doi: 10.3791/64773. PMID: 37318243
Theruvath J, Menard M, Smith BAH, Linde M, Coles GL, Wu W, Kiru L, Delaidelli A, Silberstein J, Banuelos A, Dhingra S, Sotillo E, Heitzeneder S, Tousley A, Lattin J, Xu P, Huang J, Nasholm N, Dalton GN, He A, Kuo T, Sangalang ERB, Pons J, Barkal A, Brewer R, Marjon KD, Fernandes R, Cochran JR, Sorenson PH, Daldrup-Link HE, Weissman I, Sage J, Majeti R, Bertozzi CR, Weiss WA, Mackall CL & Majzner RG: Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication. Nature Medicine 28(2): 333-344; 2022
Pemmaraju R, Minahan R, Wang E, Schadl K, Daldrup-Link H, Habte F. Web-based Application for Biomedical Image Registry, Analysis and Translation. Tomography 8(3), 1453-1462; 2022
Moore SM, Quirk JD, Lassiter AW, Laforest R, Ayers GD, Badea CT, Fedorov AY, Kinahan PE, Holbrook M, Larson PEZ, Sriram R, Chenevert TL, Malyarenko D, Kurhanewicz J, McGarry Houghton A, Ross BD, Pickup S, Gee J, Zhou R, Gammon ST, Manning HC, Roudi R, Daldrup-Link HE, Lewis MT, Rubin DL, Yankeelov TE, Shoghi KI: Co-clinical Imaging Metadata Information (CIMI) for Cancer Research to Promote Open Science, Standardization, and Reproducibility in Preclinical Imaging. Tomography 2023
Peel DM, Ackerman JJ, Badea CT, Chenevert TL, Daldrup-Link HE, Ding L, Dobrolecki L, McGarry Houghton A, Kinahan PE, Kurhanewicz J, Lewis TM, Li S, Luker G, Ma CX, Manning HC, Mowery YM, O’Dwyer P, Pautler RG, Roudi R, Rosen M, Ross BD, Shoghi KI, Sriram R, Talpaz M, Wahl RL, Zhou R. Animal Models and Their Role in Imaging-assisted Co-clinical Trials, Tomography 9(2), 657-680, 2023; https://doi.org/10.3390/tomography9020053
Aghighi M*, Theruvath A*, Pareek A, Pisani L, Alford R, Muehe A, Sethi K, Holdsworth S, Hazard FK, Gratzinger D, Luna-Fineman S, Advani R, Spunt S, Daldrup-Link H. MR Imaging of tumor associated macrophages: Clinical translation. Clin Cancer Research 24(17):4110-4118; 2018 (*Co-first authors) * featured on the cover of “Clinical Cancer Research”
http://clincancerres.aacrjournals.org/content/24/17.cover-expansion
Mohanty S, Aghighi M, Yerneni K, Theruvath JL, Daldrup-Link H. Improving the efficacy of osteosarcoma therapy: Combining drugs that turn cancer cell “don’t eat me” signal off and “eat me” signal on. Molecular Oncology 13(10): 2049–2061; 2019 * Cover Article
Mohanty S, Yerneni K, Graef CM, Theruvath JL, Nejadnik H, Lenkov O, Pisani L, Mitra S, Sweet Cordero A, Cheshier S, Daldrup-Link H. Imaging therapy response of osteosarcoma to anti-CD47 therapy. Cell Death & Disease 10(2): 36-49, 2019
Mukherjee S, Sonanini D, Maurer A, Daldrup-Link H. “The yin and yang of imaging tumor associated macrophages with PET and MRI”. Theranostics 2019; 9(25): 7730-7748
Presentations
H. Daldrup-Link: Nanotechnology in Pediatric Cancer Imaging
Whole Body PET/MRI of Children with Cancer
Cancer Imaging and Early Detection Program:
https://med.stanford.edu/cancer/research/research-programs/imaging.html
Ferumoxytol Theranostics: